Home » Currently Reading:

About

About Procto-Med.com

Procto-Med.com is produced by editors and journalists dedicated to delivering accurate, trusted, up-to-date health and medical information, for consumers. We focus on problem-solving content to help you make decisions during complicated, stressful times. We write in plain English, using real-life examples. For additional medical and diagnostic information we partner with the medically accredited sources listed below.

Editorial Team

Procto-Med.com is lead by Editorial Director Robert Calypso, an award-winning editor with experience in health, nutrition, science, food, and lifestyle content. Our talented staff of editors has worked for such health and science publications and websites as Reuters Health, HealthDay, Prevention, and more.

Accuracy and Review of Content

Hundreds of doctors, experts, patients, and advocates have been interviewed during the production of our original content. Our content is also fact-checked and reviewed periodically for accuracy.

Read our User’s Bill of Rights and Editorial Policy to learn more about our commitment to editorial integrity and service to our users.

About Your Privacy

We know that health is a very personal, private subject, and we maintain a strict privacy policy.

Community Overview

Our Message Boards, Newsletters, and Live Events provide you with ample opportunity to share your experience with others and get information that is most relevant to you.

ADS:

Featured Content:

Functional Remodeling Of Benign Human Prostatic Tissues In Vivo By Spontaneously Immortalized Progenitor And Intermediate Cells

March 18, 2010

UroToday.com – Adult tissue regeneration or remodeling is suggested to initiate from multipotent stem and/or progenitor cells. We recently reported two new human adult non-tumorigenic prostatic epithelial cell lines NHPrE1 and BHPrE1, which were generated and characterized in our laboratory. NHPrE1 cells were designated as putative progenitor cells, showing high expression levels of stem cells-associated proteins CD133, CD44, OCT4 and PTEN as detected by immunofluorescence (IF) staining and Western blotting…

Go to Source… Continue reading

Functional Remodeling Of Benign Human Prostatic Tissues In Vivo By Spontaneously Immortalized Progenitor And Intermediate Cells

March 18, 2010

UroToday.com – Adult tissue regeneration or remodeling is suggested to initiate from multipotent stem and/or progenitor cells. We recently reported two new human adult non-tumorigenic prostatic epithelial cell lines NHPrE1 and BHPrE1, which were generated and characterized in our laboratory. NHPrE1 cells were designated as putative progenitor cells, showing high expression levels of stem cells-associated proteins CD133, CD44, OCT4 and PTEN as detected by immunofluorescence (IF) staining and Western blotting…

Go to Source… Continue reading

Functional Remodeling Of Benign Human Prostatic Tissues In Vivo By Spontaneously Immortalized Progenitor And Intermediate Cells

March 18, 2010

UroToday.com – Adult tissue regeneration or remodeling is suggested to initiate from multipotent stem and/or progenitor cells. We recently reported two new human adult non-tumorigenic prostatic epithelial cell lines NHPrE1 and BHPrE1, which were generated and characterized in our laboratory. NHPrE1 cells were designated as putative progenitor cells, showing high expression levels of stem cells-associated proteins CD133, CD44, OCT4 and PTEN as detected by immunofluorescence (IF) staining and Western blotting…

Go to Source… Continue reading

Functional Remodeling Of Benign Human Prostatic Tissues In Vivo By Spontaneously Immortalized Progenitor And Intermediate Cells

March 18, 2010

UroToday.com – Adult tissue regeneration or remodeling is suggested to initiate from multipotent stem and/or progenitor cells. We recently reported two new human adult non-tumorigenic prostatic epithelial cell lines NHPrE1 and BHPrE1, which were generated and characterized in our laboratory. NHPrE1 cells were designated as putative progenitor cells, showing high expression levels of stem cells-associated proteins CD133, CD44, OCT4 and PTEN as detected by immunofluorescence (IF) staining and Western blotting…

Go to Source… Continue reading

Functional Remodeling Of Benign Human Prostatic Tissues In Vivo By Spontaneously Immortalized Progenitor And Intermediate Cells

March 18, 2010

UroToday.com – Adult tissue regeneration or remodeling is suggested to initiate from multipotent stem and/or progenitor cells. We recently reported two new human adult non-tumorigenic prostatic epithelial cell lines NHPrE1 and BHPrE1, which were generated and characterized in our laboratory. NHPrE1 cells were designated as putative progenitor cells, showing high expression levels of stem cells-associated proteins CD133, CD44, OCT4 and PTEN as detected by immunofluorescence (IF) staining and Western blotting…

Go to Source… Continue reading

Costs And Benefits Of New Chemotherapy Drugs Evaluated By Study

March 18, 2010

New chemotherapy agents appear associated with improvements in survival time for patients with metastatic colorectal cancer but at substantial cost. David H. Howard, PhD, and colleagues at Emory University’s Rollins School of Public Health (RSPH), used a cancer registry database to measure trends in life expectancy and lifetime medical costs in 4,665 patients age 66 and older diagnosed with metastatic colon cancer between 1995 and 2005…

Go to Source… Continue reading

Costs And Benefits Of New Chemotherapy Drugs Evaluated By Study

March 18, 2010

New chemotherapy agents appear associated with improvements in survival time for patients with metastatic colorectal cancer but at substantial cost. David H. Howard, PhD, and colleagues at Emory University’s Rollins School of Public Health (RSPH), used a cancer registry database to measure trends in life expectancy and lifetime medical costs in 4,665 patients age 66 and older diagnosed with metastatic colon cancer between 1995 and 2005…

Go to Source… Continue reading

Costs And Benefits Of New Chemotherapy Drugs Evaluated By Study

March 18, 2010

New chemotherapy agents appear associated with improvements in survival time for patients with metastatic colorectal cancer but at substantial cost. David H. Howard, PhD, and colleagues at Emory University’s Rollins School of Public Health (RSPH), used a cancer registry database to measure trends in life expectancy and lifetime medical costs in 4,665 patients age 66 and older diagnosed with metastatic colon cancer between 1995 and 2005…

Go to Source… Continue reading

Recent Comments:

  • symptoms of dementia: What's the difference between dementia and Alzheimers? what is the difference? I think my father may be suffering one of these? does anyone know the w...
  • rani: good blog thank 4 the info...
  • JourneyHome: McCarran-Ferguson was originally designed to empower both the federal government and the individual states so that they could act to prevent insurance...
  • Hydro Closet: Hi, I thought I would say you have a wonderful site and rich content. I bookmarked your site and have it in my reader now...looking forward to future ...
  • Allan Ono: Getting more usage from drugs already approved by the FDA for new indications seems like a very good way to expand treatment options without the hyper...